Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine review


Journal Article (Review)

These studies generally support the use of the SSRIs fluvoxamine, sertraline, and fluoxetine in the acute treatment of pediatric non-OCD anxiety disorders. Two large multicenter studies suggest a favorable outcome for paroxetine in the treatment of pediatric social anxiety disorder. Mixed results currently exist for the use of extended-release venlafaxine in the treatment of pediatric generalized anxiety disorder. In both of these latter studies, concerns with safety were present.

Duke Authors

Cited Authors

  • Compton, SN; Kratochvil, CJ; March, JS

Published Date

  • July 1, 2007

Published In

Volume / Issue

  • 37 / 7

Start / End Page

  • 504 - 517

International Standard Serial Number (ISSN)

  • 0048-5713

Citation Source

  • Scopus